ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Astrazeneca 31

Astrazeneca 31 (50UC)

108.00
-0.175
(-0.16%)
Closed June 28 10:30AM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 23B22.47B22.09B24.38B26.62B37.42B44.35B45.81B
Operating Income 3.68B2.09B1.4B1.59B4.08B-293M3.54B7.89B
Pre Tax Income 3.55B2.23B1.99B1.55B3.92B-265M2.5B6.9B
Net Income 3.5B3B2.16B1.34B3.2B112M3.29B5.96B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 2.7662.371.7011.0172.4350.0722.1223.842
EBIT 4.87B3.46B3.27B2.81B5.14B216M3.75B8.18B
EBITDA 6.04B5.11B5.15B5.35B7.23B6.24B9.02B13.28B

Your Recent History

Delayed Upgrade Clock